<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26915619</article-id>
      <article-id pub-id-type="pmc">4773271</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2016.36.3.268</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Marked Increase of Circulating Double-Negative &#x3B3;&#x3B4; T Cells in a Patient With Hydroa Vacciniforme-Like Lymphoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>Sang-Yong</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Chang-Hun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Duck</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hee-Jin</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Sun-Hee</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Laboratory Medicine &amp; Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Sun-Hee Kim. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea. Tel: +82-2-3410-2704, Fax: +82-2-3410-2719, <email>sunnyhk@skku.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>2</month>
        <year>2016</year>
      </pub-date>
      <volume>36</volume>
      <issue>3</issue>
      <fpage>268</fpage>
      <lpage>270</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>04</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>2</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>Hydroa vacciniforme-like lymphoma (HVLL) is a disorder of childhood that is associated with Epstein&#x2013;Barr virus (EBV). The characteristic clinical sign of HVLL is papulovesicular eruption and subsequent ulceration/scarring primarily on the face and upper extremities [<xref rid="B1" ref-type="bibr">1</xref>]. The neoplastic cells of HVLL are usually T cells and natural killer (NK) cells. Recently, increase of circulating EBV-infected &#x3B3;&#x3B4; T cells has been demonstrated in patients with HVLL [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref>]. We report an unusual case of marked double-negative (CD4-negative/CD8-negative) &#x3B3;&#x3B4; T cell lymphocytosis, wherein the morphological findings resembled those of larger granular lymphocytic leukemia (LGL).</p>
    <p>A 4-yr-old girl presented with multiple facial erythematous papules and crust/patches. She had a history of persistent lymphocytosis (for seven months). At the time of visit to our hospital, her white blood cell (WBC) count, hemoglobin, and platelet levels were 29.44&#xD7;10<sup>9</sup>/L (lymphocytes: 76.6%, 22.55&#xD7;10<sup>9</sup>/L), 12.2 g/dL, and 364&#xD7;10<sup>9</sup>/L, respectively. Serologic results for EBV infection were as follows: EBV-viral capsid antigen (EB-VCA) IgG, positive; EB-VCA IgM, negative; EBV-early antigen (EBV-EA), negative; EBV-nuclear antigen (EBNA) IgG, positive. The quantitative PCR result for EBV DNA was 186,620 copies/mL. Large granular lymphocytes and small lymphocytes without significant atypia increased in the peripheral blood (PB) (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). Immunophenotyping revealed increase of double-negative &#x3B3;&#x3B4; T cells in the PB (83% of lymphocytes); surface CD3-positive/CD4-negative/CD8-negative/CD16-negative/CD56-negative/CD57-negative/T cell receptor (TCR)-&#x3B3;&#x3B4;-positive (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). The flow cytometer, FACSCantoII, and monoclonal antibodies were purchased from Becton Dickinson (San Jose, CA, USA). Immunohistochemical staining results for the facial skin biopsies were as follows: CD3-positive, TCR-&#x3B2;F1-negative, TCR-C&#x3B3;M1-positive, CD4-negative, CD8-negative, CD20-negative, EBV <italic>in situ</italic> hybridization-positive, and Ki-67-positive (30%). To exclude T cell LGL (T-LGL), we analyzed <italic>STAT3</italic> using PCR and sequencing after obtaining informed consent [<xref rid="B5" ref-type="bibr">5</xref>]. Primers for <italic>STAT3</italic> were as follows: exon 19, Forward 5'-TTGGAACGAAGGGTAGGTTG-3' and Reverse 5'-TTTGCGAGTCTGAGTGAAACA-3'; exon 20, Forward 5'-CCCCTTCGAGGAAAGAAAAA-3' and Reverse 5'-CCAGGTTATTCAGGCATTTG-3'; exons 21-22, Forward 5'-GCAGATGGAGCTTTCCAGAC-3', Reverse 5'-TCCTACCATTCCGAGTGACC-3'. Sequencing was performed by using the BigDye Terminator Cycle Sequencing Ready Reaction Kit on the ABI Prism 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). No mutations were found in <italic>STAT3</italic>. HVLL was diagnosed according to the 2008 WHO Classification [<xref rid="B6" ref-type="bibr">6</xref>].</p>
    <p>Absolute lymphocytosis is unusual in hydroa vacciniforme-like lymphoproliferative disease [<xref rid="B3" ref-type="bibr">3</xref><xref rid="B6" ref-type="bibr">6</xref>]. Cytomorphological analysis of the neoplastic cells generally shows small-to-medium-sized cells without significant atypia. However, increase in large granular lymphocytes has been reported in some cases [<xref rid="B7" ref-type="bibr">7</xref>]. Large granular lymphocytosis is a prominent feature of T-LGL or chronic lymphoproliferative disorder of NK cells (CLPD-NK) [<xref rid="B8" ref-type="bibr">8</xref>]. Therefore, we analyzed the <italic>STAT3</italic> mutation, a relatively specific molecular marker of T-LGL or CLPD-NK (20-40%) [<xref rid="B5" ref-type="bibr">5</xref>]. We also analyzed CD57 expression by flow cytometry (usually positive in T-LGL) [<xref rid="B5" ref-type="bibr">5</xref>]. We excluded T-LGL on the basis of negative CD57 expression, wild-type <italic>STAT3</italic> expression, and skin biopsy results.</p>
    <p>Recently, Kimura et al. [<xref rid="B3" ref-type="bibr">3</xref>] reported increase (&gt;5% lymphocytes) of double-negative &#x3B3;&#x3B4; T cells in hydroa vacciniforme-like lymphoproliferative diseases (10/11, 90.9%), with a mean value of 15.7%&#xB1;2.9% (0.266&#xB1;0.108&#xD7;10<sup>9</sup>/L); the &#x3B3;&#x3B4; T-cell fractions had higher EBV DNA concentrations than non-&#x3B3;&#x3B4; T cell fractions. Similar results were observed in other studies [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B4" ref-type="bibr">4</xref>]. The clinical and pathologic significance of circulating &#x3B3;&#x3B4; T cells has not been fully understood until now. &#x3B3;&#x3B4; T cells are generally predominant in the epithelium of the skin and mucosa. These cells play a role in innate and acquired immune regulatory functions. Considering the clonal T cell proliferation (confirmed by TCR rearrangement analysis) and clonal EBV proliferation (confirmed by terminal repeat analysis), &#x3B3;&#x3B4; T cells may be important for the development of hydroa vacciniforme-like lymphoproliferative diseases [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref>].</p>
    <p>HVLL is a rare disease and can remain undiagnosed or be misdiagnosed (e.g., cutaneous lupus and cellulitis) owing to prominent skin manifestations without an abnormal complete blood count [<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref>]. Our patient remained undiagnosed for seven months although lymphocytosis with skin manifestations was persistent. Therefore, clinicians must rule out HVLL in children with multiple facial erythematous papules and crust/patches. Furthermore, complete blood count, peripheral blood smear, and serologic tests for EBV should be performed; subsequent flow cytometry and skin biopsy may help rule out lymphoproliferative diseases.</p>
    <p>In conclusion, we report an unusual case of marked double-negative &#x3B3;&#x3B4; T cell large granular lymphocytosis in a patient with HVLL. Although cytomorphological analysis of the neoplastic cells generally shows small-to-medium-sized cells without significant atypia, the findings for our case suggest that larger granular lymphocytes may be a prominent feature of HVLL, similar to T-LGL or CLPD-NK. Therefore, flow cytometry or STAT3 sequencing analysis may aid in differential diagnosis.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quintanilla-Martinez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ridaura</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nagl</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>S&#xE1;ez-de-Ocariz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dur&#xE1;n-McKinster</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ruiz-Maldonado</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma</article-title>
          <source>Blood</source>
          <year>2013</year>
          <volume>122</volume>
          <fpage>3101</fpage>
          <lpage>3110</lpage>
          <pub-id pub-id-type="pmid">23982171</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamauchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nishiyama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Iwata</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iwatsuki</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases</article-title>
          <source>J Infect Dis</source>
          <year>2009</year>
          <volume>200</volume>
          <fpage>1078</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="pmid">19698076</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tsuji</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected &#x3B3;&#x3B4; T cells</article-title>
          <source>J Invest Dermatol</source>
          <year>2012</year>
          <volume>132</volume>
          <fpage>1401</fpage>
          <lpage>1408</lpage>
          <pub-id pub-id-type="pmid">22297643</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawabe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Gotoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases</article-title>
          <source>Cancer Sci</source>
          <year>2012</year>
          <volume>103</volume>
          <fpage>1481</fpage>
          <lpage>1488</lpage>
          <pub-id pub-id-type="pmid">22497716</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jerez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Clemente</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Makishima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Koskela</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Leblanc</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Peng Ng</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>120</volume>
          <fpage>3048</fpage>
          <lpage>3057</lpage>
          <pub-id pub-id-type="pmid">22859607</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <source>WHO classification of tumors of haematopoietic and lymphoid tissues</source>
          <edition>4th ed</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC</publisher-name>
          <year>2008</year>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Heo</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Rim</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2001</year>
          <volume>26</volume>
          <fpage>242</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="pmid">11422165</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rashid</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khurshid</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>T-cell large granular lymphocytic leukemia: 4 cases</article-title>
          <source>Blood Res</source>
          <year>2014</year>
          <volume>49</volume>
          <fpage>203</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="pmid">25325044</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Hydroa vacciniforme-like lymphoma misdiagnosed as cutaneous lupus erythematosus</article-title>
          <source>J Cutan Pathol</source>
          <year>2015</year>
          <volume>42</volume>
          <fpage>229</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="pmid">25488018</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Plaza</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sangueza</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma</article-title>
          <source>Am J Dermatopathol</source>
          <year>2015</year>
          <volume>37</volume>
          <fpage>20</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">25162933</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Cytomorphological and immunophenotypic results for lymphocytes in the peripheral blood. (A) Large granular lymphocytes and small lymphocytes without significant atypia increased (Wright stain, &#xD7;1,000). (B) Surface CD3-positive/CD4-negative/CD8-negative/CD16-negative/CD56-negative/CD57-negative/T cell receptor (TCR)-&#x3B3;&#x3B4;-positive T cells were noted.</title>
      </caption>
      <graphic xlink:href="alm-36-268-g001"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
